WallStreetZenWallStreetZen

NYSE: TRLV
Trulieve Cannabis Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their TRLV stock forecasts and price targets.

Forecast return on equity

Is TRLV forecast to generate an efficient return?

Company
-0.84%
Industry
132.47%
Market
132.47%
TRLV's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is TRLV forecast to generate an efficient return on assets?

Company
-0.35%
Industry
74.42%

TRLV earnings per share forecast

What is TRLV's earnings per share in the next 2 years based on estimates from 8 analysts?

Avg 1 year Forecast
-$0.10
Avg 2 year Forecast
-$0.05

TRLV revenue forecast

What is TRLV's revenue in the next 2 years based on estimates from 9 analysts?

Avg 1 year Forecast
$1.2B+3.23%
Avg 2 year Forecast
$1.2B+6.57%
TRLV's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

TRLV revenue growth forecast

How is TRLV forecast to perform vs companies and vs the US market?

Company
3.23%
Industry
23.19%
Market
23.19%
TRLV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

Trulieve Cannabis Stock Forecast FAQ

What is TRLV's earnings growth forecast for 2026-2027?

(NYSE: TRLV) Trulieve Cannabis's forecast annual earnings growth rate of N/A is not forecast to beat the US industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of 1,354.43%.

Trulieve Cannabis's earnings in 2026 is -$81,105,000.On average, 8 Wall Street analysts forecast TRLV's earnings for 2026 to be -$18,826,869, with the lowest TRLV earnings forecast at -$37,692,200, and the highest TRLV earnings forecast at $2,019,225.

In 2027, TRLV is forecast to generate -$9,807,664 in earnings, with the lowest earnings forecast at -$16,961,490 and the highest earnings forecast at -$4,038,450.

If you're new to stock investing, here's how to buy Trulieve Cannabis stock.

What is TRLV's revenue growth forecast for 2026-2027?

(NYSE: TRLV) Trulieve Cannabis's forecast annual revenue growth rate of 3.23% is not forecast to beat the US industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.19%.

Trulieve Cannabis's revenue in 2026 is $1,170,174,000.On average, 9 Wall Street analysts forecast TRLV's revenue for 2026 to be $232,307,031,160, with the lowest TRLV revenue forecast at $219,807,066,735, and the highest TRLV revenue forecast at $248,076,217,050.

In 2027, TRLV is forecast to generate $239,807,009,815 in revenue, with the lowest revenue forecast at $227,499,352,535 and the highest revenue forecast at $254,037,738,545.

What is TRLV's forecast return on assets (ROA) for 2026-2027?

(NYSE: TRLV) forecast ROA is -0.35%, which is lower than the forecast US null industry average of N/A.

What is TRLV's Earnings Per Share (EPS) forecast for 2026-2027?

(NYSE: TRLV) Trulieve Cannabis's current Earnings Per Share (EPS) is -$0.42. On average, analysts forecast that TRLV's EPS will be -$0.10 for 2026, with the lowest EPS forecast at -$0.20, and the highest EPS forecast at $0.01. In 2027, TRLV's EPS is forecast to hit -$0.05 (min: -$0.09, max: -$0.02).

What is TRLV's forecast return on equity (ROE) for 2026-2027?

(NYSE: TRLV) forecast ROE is -0.84%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.